@wsj.com on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

The Wall Street Journal

wsj.com

did:plc:i3fhjvvkbmirhyu4aeihhrnv

The deal adds navtemadlin—a drug candidate for a rare blood cancer in late-stage clinical trials—to Ipsen’s oncology pipeline. on.wsj.com/44lKzch https://on.wsj.com/44lKzch

2026-06-29T05:37:26.368Z